Bob Casey: “Without a statement of policy on rare diseases and orphan products, it…”

On the recordJuly 20, 2010

Without a statement of policy on rare diseases and orphan products, it is not possible [for the FDA] to ensure consistency in that process.

Said by

Democratic · Pennsylvania

Source

Emphasizes the need for FDA policy on rare diseases for consistent treatment processes.

More from Bob Casey

Aug 21, 2024

They're selling you a lie. It's in the bag with the diapers. Prices are up because these corporations are scheming to drive them up.

Sep 12, 2024

I hope that the Committee will be able to hear from him soon.

Sep 11, 2024

I hope that the Committee will be able to hear from him soon.

Sep 12, 2024

I am disappointed that Dr. de la Torre defied the subpoena this Committee authorized and has chosen not to appear today.

Other voices in this conversation

Bob Casey: “Without a statement of policy on rare diseases and orphan products, it is not possible [for the FDA] to ensure…”